This can be demonstrated in our data in which individuals with a negative screening assay with IBD had lower hemoglobin values and albumin values at the time of diagnosis which corrected after adjustment for baseline differences in testing location and patient age. This evidence concerns the gene ALB and inflammatory bowel disease.